Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Oxidized low-density lipoprotein (oxLDL) particles contain low molecular weight species which are cytotoxic and pro-atherogenic. Many of these substances were recently isolated and purified from oxLDL, and identified as phosphatidylcholine species containing a fragmented, oxidized short-chain fatty acid remnant at the sn-2 position. KDdiA-PC is one of the most potent CD36 ligands among the oxLDL species. KDdiA-PC confers CD-36 scavenger receptor binding affinity to LDL at a frequency of only two to three KDdiA-PC molecules/LDL particle, and may be one of the more important structural determinants of oxLDL.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 μg | 35 days | $ 125.00 | |
1 mg | 35 days | $ 235.00 | |
5 mg | 35 days | $ 973.00 | |
10 mg | 35 days | $ 1,700.00 |
Description | Oxidized low-density lipoprotein (oxLDL) particles contain low molecular weight species which are cytotoxic and pro-atherogenic. Many of these substances were recently isolated and purified from oxLDL, and identified as phosphatidylcholine species containing a fragmented, oxidized short-chain fatty acid remnant at the sn-2 position. KDdiA-PC is one of the most potent CD36 ligands among the oxLDL species. KDdiA-PC confers CD-36 scavenger receptor binding affinity to LDL at a frequency of only two to three KDdiA-PC molecules/LDL particle, and may be one of the more important structural determinants of oxLDL. |
Molecular Weight | 719.894 |
Formula | C36H66NO11P |
CAS No. | 439904-34-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF: 0.5 mg/mL
Ethanol: 30 mg/mL
PBS (pH 7.2): 5 mg/mL
DMSO: 0.5 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KDdiA-PC 439904-34-4 KDdiA PC KDdiAPC inhibitor inhibit